The unadjusted odds (in binary logistic regression analysis) of a breast cancer being MF/MC in BRCA2 mutation carriers was 5.8 times greater than in a BRCA1 mutation carrier who developed breast cancer (CI: 3.31–10.12) (p < 0.001) (Table 2). The gene discussed is BRCA2; the disease is breast carcinoma.